# Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)

Study · id `cardio:ct-nct04562805` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04562805](<https://clinicaltrials.gov/study/NCT04562805>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04562805

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 2400 participants.

## Technical summary

Registry record NCT04562805. Randomized; single masking; primary purpose treatment. Start 2020-09-30 (actual); primary completion 2024-09-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 2400 participants (planned count; ClinicalTrials.gov record NCT04562805, source copy `cardio:ctgov-nct04562805-2024-10-16`, retrieved 2026-10-26)
- Started: 2020-09-30 (actual) (ClinicalTrials.gov record NCT04562805, source copy `cardio:ctgov-nct04562805-2024-10-16`, retrieved 2026-10-26)
- Primary completion: 2024-09-05 (actual) (ClinicalTrials.gov record NCT04562805, source copy `cardio:ctgov-nct04562805-2024-10-16`, retrieved 2026-10-26)
- Completion: 2028-07-31 (anticipated) (ClinicalTrials.gov record NCT04562805, source copy `cardio:ctgov-nct04562805-2024-10-16`, retrieved 2026-10-26)
- Countries: Sweden (ClinicalTrials.gov record NCT04562805, source copy `cardio:ctgov-nct04562805-2024-10-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04562805-2024-10-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)
- Condition: Coronary Artery Disease
- Condition: Ischemic Heart Disease
- Intervention (Device): DynamX Bioadaptor
- Intervention (Device): Resolute Onyx
- Lead sponsor: Elixir Medical Corporation
- Lead sponsor class: INDUSTRY
- Collaborator: Uppsala University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Elixir Medical Corporation (`cardio:org-elixir-medical-corporation`)
- Registry lists this organization as a collaborator: Uppsala University (`cardio:org-uppsala-university`)

## Provenance

Content hash: cbd46e1c7588e131e905ca37ec467928087057e4840d99cee454d76f71173df5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
